BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21228324)

  • 1. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.
    Gillet NA; Malani N; Melamed A; Gormley N; Carter R; Bentley D; Berry C; Bushman FD; Taylor GP; Bangham CR
    Blood; 2011 Mar; 117(11):3113-22. PubMed ID: 21228324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.
    Cook LB; Melamed A; Niederer H; Valganon M; Laydon D; Foroni L; Taylor GP; Matsuoka M; Bangham CR
    Blood; 2014 Jun; 123(25):3925-31. PubMed ID: 24735963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
    Satou Y; Miyazato P; Ishihara K; Yaguchi H; Melamed A; Miura M; Fukuda A; Nosaka K; Watanabe T; Rowan AG; Nakao M; Bangham CR
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3054-9. PubMed ID: 26929370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
    Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
    PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers.
    Tanaka G; Okayama A; Watanabe T; Aizawa S; Stuver S; Mueller N; Hsieh CC; Tsubouchi H
    J Infect Dis; 2005 Apr; 191(7):1140-7. PubMed ID: 15747250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1-infected T cells contain a single integrated provirus in natural infection.
    Cook LB; Rowan AG; Melamed A; Taylor GP; Bangham CR
    Blood; 2012 Oct; 120(17):3488-90. PubMed ID: 22955925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality of HTLV-2 in natural infection.
    Melamed A; Witkover AD; Laydon DJ; Brown R; Ladell K; Miners K; Rowan AG; Gormley N; Price DA; Taylor GP; Murphy EL; Bangham CR
    PLoS Pathog; 2014 Mar; 10(3):e1004006. PubMed ID: 24626195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection.
    Melamed A; Laydon DJ; Gillet NA; Tanaka Y; Taylor GP; Bangham CR
    PLoS Pathog; 2013 Mar; 9(3):e1003271. PubMed ID: 23555266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
    Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
    PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
    Melamed A; Laydon DJ; Al Khatib H; Rowan AG; Taylor GP; Bangham CR
    Retrovirology; 2015 Nov; 12():91. PubMed ID: 26552867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.
    Gillet NA; Gutiérrez G; Rodriguez SM; de Brogniez A; Renotte N; Alvarez I; Trono K; Willems L
    PLoS Pathog; 2013; 9(10):e1003687. PubMed ID: 24098130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.
    Bangham CR; Cook LB; Melamed A
    Semin Cancer Biol; 2014 Jun; 26():89-98. PubMed ID: 24316494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis.
    Melamed A; Yaguchi H; Miura M; Witkover A; Fitzgerald TW; Birney E; Bangham CR
    Elife; 2018 Jun; 7():. PubMed ID: 29941091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative contributions of infectious and mitotic spread to HTLV-1 persistence.
    Laydon DJ; Sunkara V; Boelen L; Bangham CRM; Asquith B
    PLoS Comput Biol; 2020 Sep; 16(9):e1007470. PubMed ID: 32941445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clonal expansion and genomic characterization of the human T-cell lymphotropic virus type I during the integration process in adult T-cell leukemia/lymphoma].
    Salcedo-Cifuentes M; Cabrera J; Cuesta-Astroz Y; Carrasca E; Eizuru Y; Domínguez MC; Sánchez A; García-Vallejo F
    Biomedica; 2009 Jun; 29(2):218-31. PubMed ID: 20128347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP.
    Meekings KN; Leipzig J; Bushman FD; Taylor GP; Bangham CR
    PLoS Pathog; 2008 Mar; 4(3):e1000027. PubMed ID: 18369476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients.
    Cook LB; Melamed A; Demontis MA; Laydon DJ; Fox JM; Tosswill JH; de Freitas D; Price AD; Medcalf JF; Martin F; Neuberger JM; Bangham CR; Taylor GP
    Retrovirology; 2016 Jan; 13():3. PubMed ID: 26745892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers.
    Takenouchi H; Umeki K; Sasaki D; Yamamoto I; Nomura H; Takajo I; Ueno S; Umekita K; Kamihira S; Morishita K; Okayama A
    Int J Cancer; 2011 Mar; 128(6):1335-43. PubMed ID: 20473938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
    Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
    Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.